Connect Biopharma (CNTB) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.91, +0.03% vs the prior close of $0.91.
- Volume 570.43K shares, 0.1x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CNTB ends flat (+0.0%) to $0.91. Closed at $0.91, +0.03% vs the prior close of $0.91. Day range $0.87–$0.91, opened at $0.89.
CNTB daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — CNTB ends flat (+0.0%) to $0.91
- Closed at $0.91, +0.03% vs the prior close of $0.91. Day range $0.87–$0.91, opened at $0.89.
- Volume was 570.43K shares, 0.1x its 50-day average of 4.88M — lighter than usual.
- Price is -45.6% vs its 50-day average ($1.67) and -60.1% vs its 200-day average ($2.27).
- 52-week range $0.85–$3.82; today's close sits at 2% of that range, 76.3% below the 52-week high.
Oct 15, 2026 — CNTB dips 0.3% to $0.91
- Closed at $0.91, -0.33% vs the prior close of $0.91. Day range $0.88–$0.93, opened at $0.89.
- Volume was 1.51M shares, 0.3x its 50-day average of 4.86M — lighter than usual.
- Price is -46.5% vs its 50-day average ($1.69) and -60.2% vs its 200-day average ($2.28).
- 52-week range $0.85–$3.82; today's close sits at 2% of that range, 76.3% below the 52-week high.
Oct 14, 2026 — CNTB dips 1.1% to $0.91
- Closed at $0.91, -1.09% vs the prior close of $0.92. Day range $0.87–$0.93, opened at $0.89.
- Volume was 1.10M shares, 0.2x its 50-day average of 4.84M — lighter than usual.
- Price is -47.1% vs its 50-day average ($1.72) and -60.2% vs its 200-day average ($2.29).
- 52-week range $0.85–$3.82; today's close sits at 2% of that range, 76.2% below the 52-week high.
Oct 13, 2026 — CNTB rises 1.4% to $0.92
- Closed at $0.92, +1.43% vs the prior close of $0.91. Day range $0.87–$0.93, opened at $0.90.
- Volume was 1.78M shares, 0.4x its 50-day average of 4.81M — lighter than usual.
- Price is -47.2% vs its 50-day average ($1.74) and -60.0% vs its 200-day average ($2.30).
- 52-week range $0.85–$3.82; today's close sits at 2% of that range, 75.9% below the 52-week high.
Oct 12, 2026 — CNTB jumps 4.1% to $0.91
- Closed at $0.91, +4.14% vs the prior close of $0.87. Day range $0.88–$0.93, opened at $0.91.
- Volume was 1.62M shares, 0.3x its 50-day average of 4.79M — lighter than usual.
- Price is -48.6% vs its 50-day average ($1.76) and -60.7% vs its 200-day average ($2.30).
- 52-week range $0.85–$3.82; today's close sits at 2% of that range, 76.3% below the 52-week high.
Oct 9, 2026 — CNTB dips 1.2% to $0.87, a 52-week low
- Closed at $0.87, -1.25% vs the prior close of $0.88. Day range $0.87–$0.93, opened at $0.88.
- Volume was 1.05M shares, 0.2x its 50-day average of 4.77M — lighter than usual.
- Price is -51.3% vs its 50-day average ($1.78) and -62.4% vs its 200-day average ($2.31).
- 52-week range $0.85–$3.82; today's close sits at 1% of that range, 77.2% below the 52-week high.
Oct 8, 2026 — CNTB slides 6.8% to $0.88, a 52-week low
- Closed at $0.88, -6.77% vs the prior close of $0.94. Day range $0.88–$0.96, opened at $0.93.
- Volume was 1.21M shares, 0.3x its 50-day average of 4.75M — lighter than usual.
- Price is -51.3% vs its 50-day average ($1.81) and -62.0% vs its 200-day average ($2.32).
- 52-week range $0.85–$3.82; today's close sits at 1% of that range, 76.9% below the 52-week high.
Oct 7, 2026 — CNTB jumps 4.4% to $0.94
- Closed at $0.94, +4.42% vs the prior close of $0.90. Day range $0.89–$0.97, opened at $0.90.
- Volume was 1.22M shares, 0.3x its 50-day average of 4.73M — lighter than usual.
- Price is -48.4% vs its 50-day average ($1.83) and -59.4% vs its 200-day average ($2.33).
- 52-week range $0.85–$3.82; today's close sits at 3% of that range, 75.3% below the 52-week high.
Oct 6, 2026 — CNTB rises 0.8% to $0.90
- Closed at $0.90, +0.78% vs the prior close of $0.90. Day range $0.85–$0.98, opened at $0.89.
- Volume was 1.84M shares, 0.4x its 50-day average of 4.69M — lighter than usual.
- Price is -51.2% vs its 50-day average ($1.86) and -61.2% vs its 200-day average ($2.34).
- 52-week range $0.85–$3.82; today's close sits at 2% of that range, 76.3% below the 52-week high.
Oct 5, 2026 — CNTB slides 3.1% to $0.90, a 52-week low, 3 down days in a row
- Closed at $0.90, -3.13% vs the prior close of $0.93. Day range $0.89–$0.97, opened at $0.93.
- Volume was 1.43M shares, 0.3x its 50-day average of 4.67M — lighter than usual.
- Price is -52.2% vs its 50-day average ($1.88) and -61.7% vs its 200-day average ($2.34).
- 52-week range $0.89–$3.82; today's close sits at 0% of that range, 76.5% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — CNTB slides 5.4% to $0.93, a 52-week low
- Closed at $0.93, -5.41% vs the prior close of $0.98. Day range $0.89–$1.08, opened at $0.98.
- Volume was 4.20M shares, 0.9x its 50-day average of 4.59M.
- Price is -51.3% vs its 50-day average ($1.90) and -60.5% vs its 200-day average ($2.35).
- 52-week range $0.89–$3.82; today's close sits at 1% of that range, 75.7% below the 52-week high.
CNTB latest news & SEC filings
Every SEC filing by or about CNTB in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 6, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Xanthopoulos Kleanthis Gabriel received an award of 5,000 shares on Sep 30, 2026; now holds 91,554
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Liu Jean I received an award of 8,984 shares on Sep 30, 2026; now holds 20,763
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Sep 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $2.77M (prior year $48.00K) (+5666.7% vs Jun 30, 2025)
- Net income: -$17.28M (prior year -$12.90M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.27 (prior year -$0.23) (loss widened vs Jun 30, 2025)
Aug 12, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade CNTB
- Last results release: Aug 12, 2026 (8-K Item 2.02). Previous ones: May 12, 2026, Mar 31, 2026, Nov 12, 2025. Based on that rhythm, the next report is likely around Nov 11, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 4.32% (largest 11.9%). That is a volatile stock.
- Liquidity: about 10.04M shares (≈$9.10M) trade per day on average.
- 52-week position: $0.91 vs a range of $0.85–$3.82 (2% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 8 open-market buys, 0 sales; latest: James Huang bought 150,000 shares on May 29, 2026.
- Latest filings: 8-K Sep 30, 2026; 8-K Sep 15, 2026; 10-Q Aug 12, 2026.
- Share count: 62.97M shares outstanding (Jul 31, 2026), +13.0% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
CNTB market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.89 | 0.91 | 0.87 | 0.91 | 570.43K |
| Oct 15, 2026 | 0.89 | 0.93 | 0.88 | 0.91 | 1.51M |
| Oct 14, 2026 | 0.89 | 0.93 | 0.87 | 0.91 | 1.10M |
| Oct 13, 2026 | 0.90 | 0.93 | 0.87 | 0.92 | 1.78M |
| Oct 12, 2026 | 0.91 | 0.93 | 0.88 | 0.91 | 1.62M |
| Oct 9, 2026 | 0.88 | 0.93 | 0.87 | 0.87 | 1.05M |
| Oct 8, 2026 | 0.93 | 0.96 | 0.88 | 0.88 | 1.21M |
| Oct 7, 2026 | 0.90 | 0.97 | 0.89 | 0.94 | 1.22M |
| Oct 6, 2026 | 0.89 | 0.98 | 0.85 | 0.90 | 1.84M |
| Oct 5, 2026 | 0.93 | 0.97 | 0.89 | 0.90 | 1.43M |
| Oct 2, 2026 | 0.98 | 1.08 | 0.89 | 0.93 | 4.20M |
| Oct 1, 2026 | 1.12 | 1.12 | 0.94 | 0.98 | 7.94M |
| Sep 30, 2026 | 1.89 | 1.89 | 1.07 | 1.10 | 165.63M |
| Sep 29, 2026 | 1.06 | 1.09 | 0.98 | 0.99 | 1.60M |
| Sep 28, 2026 | 1.08 | 1.11 | 1.05 | 1.08 | 2.46M |
| Sep 25, 2026 | 1.09 | 1.12 | 1.06 | 1.08 | 803.50K |
| Sep 24, 2026 | 1.07 | 1.11 | 1.07 | 1.10 | 778.00K |
| Sep 23, 2026 | 1.21 | 1.23 | 1.07 | 1.07 | 1.40M |
| Sep 22, 2026 | 1.28 | 1.28 | 1.21 | 1.22 | 1.22M |
| Sep 21, 2026 | 1.27 | 1.33 | 1.20 | 1.32 | 1.35M |
About Connect Biopharma
Connect Biopharma (CNTB) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SAN DIEGO, CA. State of incorporation: Cayman Islands. Fiscal year ends December 31. SEC CIK 1835268.
CNTB board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| James Huang | Director | Jun 2, 2026 |
| Jean I Liu | Director | Jul 1, 2026 |
| Barry D Quart | Chief Executive Officer | Mar 16, 2026 |
| James A Schoeneck | Director | Mar 16, 2026 |
| Karen J Wilson | Director | Mar 16, 2026 |
| Kleanthis Gabriel Xanthopoulos | Director | Jul 1, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Lisa Peraza | Senior Vice President, Finance | Mar 16, 2026 |
| Barry D Quart | Chief Executive Officer | Mar 16, 2026 |
| David Leslie Szekeres | President | Mar 16, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 29, 2026 | James Huang | Buy | 150,000 | $2.48 |
| May 29, 2026 | James Huang | Buy | 150,000 | $2.48 |
| May 29, 2026 | James Huang | Buy | 150,000 | $2.48 |
| May 29, 2026 | James Huang | Buy | 150,000 | $2.48 |
| Mar 31, 2026 | James Huang | Buy | 1,160,000 | $3.45 |
| Mar 31, 2026 | James Huang | Buy | 1,160,000 | $3.45 |
| Mar 31, 2026 | James Huang | Buy | 1,160,000 | $3.45 |
| Mar 31, 2026 | James Huang | Buy | 1,160,000 | $3.45 |
CNTB financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $64.00K | $-55.48M | -1.00 | $-51.21M |
| Dec 31, 2024 | $26.03M | $-15.63M | -0.28 | $-23.61M |
| Dec 31, 2023 | $0 | $-62.11M | -1.13 | $-47.74M |
Latest balance sheet: total assets $43.47M, total liabilities $16.61M, cash $27.02M (as of Jun 30, 2026).
CNTB earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 12, 2026 | 8-K Item 2.02 (results) | $2.33 |
| May 12, 2026 | 8-K Item 2.02 (results) | $2.68 |
| Mar 31, 2026 | 8-K Item 2.02 (results) | $2.62 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $1.61 |
| Aug 13, 2025 | 8-K Item 2.02 (results) | $2.36 |
| May 15, 2025 | 8-K Item 2.02 (results) | $0.73 |
| Mar 31, 2025 | 8-K Item 2.02 (results) | $0.55 |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on CNTB
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.